[1]
Oya Yonal, Fatih Eren, Yusuf Yılmaz, Özlen Atuğ, and Hülya Hamzaoğlu Över, “No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects”, Turkish Journal of Gastroenterology, vol. 25, no. 6, pp. 639–643, Jul. 2019.